BCG as adjuvant immunotherapy for neoplasia

Annu Rev Med. 1977:28:489-515. doi: 10.1146/annurev.me.28.020177.002421.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibody Formation
  • Antigens, Neoplasm
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects
  • BCG Vaccine / therapeutic use*
  • Breast Neoplasms / therapy
  • Colonic Neoplasms / therapy
  • Disease Models, Animal
  • Head and Neck Neoplasms / therapy
  • Humans
  • Immunity, Cellular
  • Leukemia / therapy
  • Levamisole / therapeutic use
  • Lung Neoplasms / therapy
  • Lymphoma / therapy
  • Macrophages / immunology
  • Melanoma / therapy
  • Mononuclear Phagocyte System / immunology
  • Neoplasms / immunology
  • Neoplasms / prevention & control
  • Neoplasms / therapy*
  • T-Lymphocytes / immunology
  • Urinary Bladder Neoplasms / therapy

Substances

  • Antigens, Neoplasm
  • BCG Vaccine
  • Levamisole